UC Health leads alzheimer’s disease screening

UC Health’s UC Gardner Neuroscience Institute is leading the way in implementing cutting-edge screening tools for Alzheimer’s disease and offering patients access to the latest therapies and treatments. The UC Memory Disorders Center has partnered with Cognetivity Neurosciences, a leading artificial intelligence (AI) healthcare technology company, to implement CognICA, a cognitive assessment tool, in the clinical setting. This tool enables primary care and other specialty providers to screen patients who may be at risk for cognitive impairment, including older adults and spine surgery patients. Patients who screen positive on CognICA & will be referred to the UC Gardner Neuroscience Institute’s Memory Disorders Center and geriatricians in the health system’s primary care network for further evaluation and diagnosis, allowing detection and treatment to take place as early as possible, when it is most effective. “This collaboration with Cognetivity, a leader in rapid cognitive screening, will empower our primary care and specialty providers to smartly detect cognitive decline at its early stages and enable early intervention, which we hope will lead to lower mortality and morbidity rates,” said Rhonna Shatz, DO, a physician-researcher at the UC Gardner Neuroscience Institute and medical director of the UC Memory Disorders Center. Dr. Shatz is a...